| Symbiotec Pharmalab IPO: Domestic Funds Dominate Anchor Book, What Investors Should Watch? | ₹380 | ₹988 | Available Soon | Available Soon | 2026-09-01 |
| Skyways Air Services IPO Booked: Nomura Anchors Foreign Slice as Domestic Funds Dominate Anchor Phase | ₹50 | ₹138 | Available Soon | Available Soon | 2026-09-01 |
| Hy-Tech Engineers IPO: Anchor Investors Commit Rs 40.72 Crore. What Does This Signal? | ₹25 | ₹53 | Available Soon | Available Soon | 2026-09-01 |
| Freedom Oils Maker Gemini Edibles Files for IPO: What’s Driving its Growth? | Available Soon | Available Soon | Available Soon | Available Soon | Available Soon |
| Audiovisual Tech Firm Online Instruments Gets SEBI Nod for IPO: What’s Next? | Available Soon | Available Soon | Available Soon | Available Soon | Available Soon |
| Symbiotec Pharmalab IPO Opens: Is This Steroid Manufacturer Poised for Growth? | ₹380 | ₹988 | Available Soon | Available Soon | 2026-09-01 |
| Aether Industries Files for IPO: Can This Specialty Chemical Maker Capture Investor Interest? | Available Soon | Available Soon | Available Soon | Available Soon | Available Soon |
| Symbiotec Pharmalab Prepares for Market Debut: Is This Pharma Play a Long-Term Winner? | ₹380 | ₹988 | Available Soon | Available Soon | 2026-09-01 |
| Symbiotec Pharmalab Eyes IPO: Is This Steroid Maker a Long-Term Investment Opportunity? | Available Soon | Available Soon | Available Soon | Available Soon | Available Soon |
| Sadhana Nitrochem Files for IPO: Can This Specialty Chemicals Player Capture Market Share? | Available Soon | Available Soon | Available Soon | Available Soon | Available Soon |
